Pan-Provincial Vaccine Enterprise Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Pan-Provincial Vaccine Enterprise Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013422
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pan-Provincial Vaccine Enterprise Inc (PREVENT) is a national vaccine commercialization consortium that specializes in research and development of vaccines for infectious diseases. The institute develops vaccines for infectious disease, group A streptococcus vaccine, chlamydia vaccine, influenza-PAL vaccine, RSV-P3 vaccine and CWD vaccine. It discovers vaccine through pre-clinical to Phase l and early-Phase ll clinical evaluation. PREVENT conducts pre-clinical and early clinical platform for the introduction of new vaccines. The institute partners with public health, academic organizations, research institutes, the vaccine industry, among others. Pan-Provincial Vaccine is headquartered in Saskatoon, Saskatchewan, Canada.

Pan-Provincial Vaccine Enterprise Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Pan-Provincial Vaccine Enters Into Licensing Agreement With Folia Biotech 10
Vaxent Enters Into Licensing Agreement With Pan-Provincial Vaccine 11
Pan-Provincial Vaccine Enters Into Licensing Agreement With Amorfix Life Sciences 12
Pan-Provincial Vaccine Enterprise Inc – Key Competitors 13
Pan-Provincial Vaccine Enterprise Inc – Key Employees 14
Pan-Provincial Vaccine Enterprise Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Key Facts 2
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pan-Provincial Vaccine Enterprise Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Pan-Provincial Vaccine Enterprise Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pan-Provincial Vaccine Enters Into Licensing Agreement With Folia Biotech 10
Vaxent Enters Into Licensing Agreement With Pan-Provincial Vaccine 11
Pan-Provincial Vaccine Enters Into Licensing Agreement With Amorfix Life Sciences 12
Pan-Provincial Vaccine Enterprise Inc, Key Competitors 13
Pan-Provincial Vaccine Enterprise Inc, Key Employees 14

★海外企業調査レポート[Pan-Provincial Vaccine Enterprise Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Korea Midland Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea Midland Power Co., Ltd. (Komipo), a subsidiary of Korea Electric Power Corporation, is an electric utility which generates electricity; operates power plants; and provides various energy services. The company produces electricity from bituminous coal, anthracite coal, liquefied natural …
  • Arch Therapeutics Inc (ARTH):医療機器:M&Aディール及び事業提携情報
    Summary Arch Therapeutics Inc (Arch Therapeutics) is a medical device company that develops self-assembling barrier technologies to improve interventional wound care outcomes. The company offers hemostasis and sealant products to seal and protect leaking and bleeding tissue. It provides intervention …
  • Halliburton Co (HAL):石油・ガス:M&Aディール及び事業提携情報
    Summary Halliburton Co (Halliburton) is an oilfield services company. The company serves the upstream oil and gas industry throughout the lifecycle of the reservoir, from identifying hydrocarbons and managing geological data, to drilling and formation evaluation, well construction and completion, an …
  • Mitsui & Co Ltd (8031):石油・ガス:M&Aディール及び事業提携情報
    Summary Mitsui & Co Ltd (Mitsui) is a business conglomerate. The company sells, distributes, purchases, markets and supplies wide variety of products in business areas including iron and steel; non-ferrous metals; machinery; electronics; chemicals; energy-related commodities; foods & retail, lifesty …
  • Hyposwiss Private Bank Geneve SA:企業の戦略・SWOT・財務情報
    Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report Summary Hyposwiss Private Bank Geneve SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Halcon Resources Corp (HK):石油・ガス:M&Aディール及び事業提携情報
    Summary Halcon Resources Corp (Halcon) is an independent energy company that acquires, explores, produces, and develops onshore liquids-rich assets. The company owns and operates its oil and gas explorates resources in El Halcon of Eagle Ford shale formation and Bakken and Three Forks formations. It …
  • Nutra Pharma Corp (NPHC):医療機器:M&Aディール及び事業提携情報
    Summary Nutra Pharma Corp (Nutra Pharma) acquires, licenses and commercializes pharmaceutical products, technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, autoimmune and infectious diseases, including human Immunodeficiency virus (HIV), multiple sclerosis …
  • Midatech Pharma Plc (MTPH):企業の財務・戦略的SWOT分析
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimm …
  • Colfax Corporation (CFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Colfax Corp (Colfax) is a manufacturing and engineering company. The company supplies a wide range of products, including heavy-duty centrifugal and axial fans, gas compressors, rotary heat exchangers, and centrifugal and positive displacement pumps; and consumable products and equipment for …
  • PetroChina Co Ltd (857)-石油・ガス分野:企業M&A・提携分析
    Summary PetroChina Company Limited (PetroChina), a subsidiary of China National Petroleum Corporation, is an oil and gas company that explores for, develops and produces crude oil and natural gas; refines crude oil and petroleum products; and produces and sells basic and derivative chemical products …
  • Neusoft Corporation (600718):企業の財務・戦略的SWOT分析
    Neusoft Corporation (600718) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • LT Group, Inc. (LTG):企業の財務・戦略的SWOT分析
    LT Group, Inc. (LTG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bashneft (BANE):企業の財務・戦略的SWOT分析
    Bashneft (BANE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • PDL Biopharma, Inc.:企業の戦略・SWOT・財務分析
    PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report Summary PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Aer Lingus Ltd:企業の戦略・SWOT・財務情報
    Aer Lingus Ltd - Strategy, SWOT and Corporate Finance Report Summary Aer Lingus Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Pudumjee Paper Products Limited:企業の戦略・SWOT・財務分析
    Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report Summary Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Nissin Foods Holdings Co Ltd.:企業の戦略・SWOT・財務分析
    Nissin Foods Holdings Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissin Foods Holdings Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • MorphoSys AG (MOR):企業の財務・戦略的SWOT分析
    Summary MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, and research applications. The company’s pipeline products include MOR208, MOR103, MOR202, MAA868, VAY736, MOR106, and MOR107. Its drugs are used for the treatment of various types of cancers, psoriasis, rheuma …
  • Gold Road Resources Ltd (GOR):企業の財務・戦略的SWOT分析
    Summary Gold Road Resources Ltd (GRRL), formerly Eleckra Mines Ltd, is a mining and mineral exploration and development company that offers mining services. The company acquires, explores and develops iron, gold, nickel and mineral deposits properties. Its projects comprise Gruyere project, Yamarna …
  • Blue Energy Ltd (BUL):石油・ガス:M&Aディール及び事業提携情報
    Summary Blue Energy Ltd (BEL) is an oil and gas company that provides exploration and development services. The company provides exploration and production of coal seam gas and conventional oil, and gas resources in Australia. Its projects portfolio includes carpentaria basin, bowen basin, galilee b …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆